Response to ‘Presentation and pathophysiology of neuro-COVID’
Letter to the Editor in response to Finsterer J, Scorza FA, Scorza CA. Presentation and pathophysiology of neuro-COVID. Drugs Context. 2021;10:2021-6-5
Back to homepage
Neurology
Presentation and pathophysiology of neuro-COVID
Letter to the Editor commenting on Orsucci D, Caldarazzo Ienco E, Nocita G, Napolitano A, Vista M. Neurological features of COVID-19 and their treatment: a review. Drugs Context. 2020;9:2020-5-1.
The multiple faces of ketamine in anaesthesia and analgesia
This article provides information for the clinical use of ketamine in anaesthesia, in both conventional and special circumstances.
Corrigendum: Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
Wan GJ, Chopra I, Niewoehner J, Hunter SF. Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis. Drugs in Context 2020; 9: 2020-9-4. DOI: 10.7573/dic.2020-9-4
Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
The objective of this study was to estimate the cost per response of repository corticotropin injection compared with plasmapheresis or intravenous immunoglobulin from the United States commercial payer perspective.
